ICS 2013 Scientific Podium Poster Session S19 - Neurourology and Paediatrics

International Continence Society

Neurourology and Paediatrics

Speakers
	Scientific Podium Poster Session S19
	Thursday 29th August 2013
	14:00 - 15:30
	113 Capacity: 350
	Lunch provided
L Luis Prieto ICS Chair W Wendy F Bower ICS Chair

Summary by Luis Prieto

Demonstration highlights the second poster (No. 171). The re-sterilization of catheters for Self-catheterisation does not increase the infection rate with economic advantage and availability of catheters. The third poster of the same concept (no. 172) for patients with spina bifida, where re-sterilized catheters PVC by porcionan result like the disposable single use are more expensive. Finally excellence and obligation to eliminate obstruction in childhood, has great impact on adulthood. It is the only study on the subject of this monitoring.

Session Schedule

14:30

#169 URINARY CATHETERIZATION MAY NOT NEGATIVLEY IMPACT QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS

Presenter: Rebecca James

James R¹, Frasure H¹, Mahajan S¹
1. Case Western Reserve University
Multiple Sclerosis, Quality of Life (QoL), Voiding Dysfunction , Other [catheterization]

14:35

#170 Clean Intermittent Self-Catheterisation: A Randomised Controlled Crossover Trial of single-use versus multiple re-use of non-coated catheters; is cystitis rate altered?

Presenter: Hayley Leek

Leek H¹, Stephenson Z¹, Reus A¹, Karantanis E¹, Moore K H²
1. Pelvic Floor Unit, St George Hospital, Sydney Australia, 2. Pelvic Floor Unit, University of New South Wales
Rehabilitation, Mixed Urinary Incontinence, Voiding Dysfunction

14:40

#171 Randomised Crossover Trial of hydrophilic single use versus multiuse PVC for CIC in Children with Neural Tube Defects (Spina Bifida)

Presenter: Katherine Nancy Moore

Moore K N¹, Kiddoo D², Sawatzky B³, Afshar K⁴, Dharamsi N⁵, Bascu C⁶, Schlopflocher D⁷
1. Faculty of Nursing University of Alberta, 2. Dept of Surgery Division of Urology University of Alberta, 3. University of British Columbia, 4. Dept Urologic Sciences University of BC, BC Children's Hospital Vancouver BC, 5. Pediatric Urology, Winnipeg Health Sciences Centre Winnipeg Man, 6. Dept of Surgery Divison of Urology University of Alberta, 7. School of Public Health University of Alberta
Clinical Trial, Infection, Urinary Tract, Pediatrics, Conservative Treatment, Spinal Cord Injury

14:45

#172 Investigation of automatic nervous system activity of overactive bladder syndrome patients using an “autonomic reflex orthostatic test”

Presenter: Nobutaka Shimizu

Shimizu N¹, Tsuji H¹, Sugimoto K², Nozawa M¹, Yoshimura K¹, Uemura H¹
1. Department of Urology, Kinki University Faculty of Medicine, 2. Department of Urology, Sakai Hospital Kinki University Faculty of Medicine, Osaka, Japan
Detrusor Overactivity, New Instrumentation, Overactive Bladder

14:50

#173 Observations on the differences in response to Ice water test after treatment with Tolterodine-ER and Onabotulinum toxin A in patients with neurogenic bladder.

Presenter: Dinesh Suman

Suman D¹, Suman D²
1. Isic ,New Delhi, 2. Isic ,New Delhi
Detrusor Overactivity, Incontinence, Retrospective Study

14:55

#174 Sustained improvements in health-related quality of life following repeat onabotulinumtoxinA detrusor injections in patients with neurogenic detrusor overactivity: results from two phase 3 studies

Presenter: Emmanuel Chartier-Kastler

Chartier-Kastler E¹, Rovner E², Chancellor M³, Corbell C⁴, Jin J⁴, Globe D⁴
1. Université Paris-VI, Department of Urology, Paris, France, 2. Medical University of South Carolina, Department of Urology, Charleston, SC, USA, 3. Oakland University, William Beaumont School of Medicine, Royal Oak, MI, USA, 4. Allergan, Inc, Irvine, CA, USA
Clinical Trial, Detrusor Overactivity, Incontinence, Quality of Life (QoL)

15:00

#175 OnabotulinumtoxinA Significantly Decreases Urinary Incontinence and Provides Treatment Benefit in Patients with Idiopathic Overactive Bladder: A Pooled Analysis of Two Phase III, Placebo-Controlled Pivotal Trials

Presenter: Vikram Khullar

Khullar V¹, Nitti V², Dmochowski R³, Sand P⁴, Chapple C⁵, Sievert K⁶, MacDiarmid S⁷, Radziszewski P⁸, Nardo C⁹, Zhou J⁹, Haag-Molkenteller C⁹, Herschorn S¹⁰
1. Imperial College, London, UK, 2. New York University Langone Medical Center, New York, NY, USA, 3. Vanderbilt University Medical Center, Nashville, TN, USA, 4. Evanston Continence Center, University of Chicago, Evanston, IL, USA, 5. Royal Hallamshire Hospital, Sheffield, UK, 6. University of Tuebingen, Tuebingen, Germany, 7. Alliance Urology Specialists, Greensboro, NC, USA, 8. Medical University of Warsaw, Warsaw, Poland, 9. Allergan, Inc., Irvine, CA, USA, 10. University of Toronto, Toronto, Ontario, Canada
Overactive Bladder, Incontinence, Urgency Urinary Incontinence

15:05

#176 Onabotulinum toxin A vs resiniferatoxin in the treatment of wet overactive bladder patients: a clinical and urodynamic prospective analysis.

Presenter: André Santos-Silva

Santos-Silva A¹, Martins-Silva C², Lopes T², Silva J², Pinto R², Cruz F²
1. Urology Department, Hospital de S. João, 2. Urology Department, Hospital de S. João; Faculty of Medicine, University of Porto
Female, Incontinence, Overactive Bladder, Prospective Study

15:10

#177 Persistent urge urinary incontince in boys: comparison between conservative treatment and transurethral desobstruction.

Presenter: Pauline Hennus

Hennus P¹, de Jong T¹, Bosch J L H R¹, de Kort L¹
1. UMC Utrecht
Conservative Treatment, Surgery, Incontinence, Pediatrics

15:15

#178 Impact of posterior urethral diameter / external urethral diameter ratio as a new tool to predict high detrusor pressure in voiding phase in children

Presenter: Masafumi Kon

Kon M¹, Mitsui T¹, Moriya K¹, Kitta T¹, Nonomura K¹
1. Department of Urology Hokkaido University Graduate School of Medicine
Imaging, Urodynamics Techniques, Pediatrics, Voiding Dysfunction

15:20

#179 Bladder capacity. New models for children’s normal Maximum Voided Volumes

Presenter: Roberto Martinez-Garcia

Martinez-Garcia R¹, Ubeda-Sansano M I², Díez-Domingo J³, Pérez-Hoyos S⁴, Gil-Salom M⁵
1. Urologist. Department of Urology. Clinic University Hospital of Valencia., 2. Pediatrician. Primary Health Care Centre. VIVA team member, 3. Resercher of the Center for Public Health Research (CSISP), FISABIO of Valencia. VIVA Team member., 4. Estatistician. Unitat Suport Metodològic a l'Investigació Biomedica (USMIB). Institut de Recerca Hospital Vall Hebrón. Barcelona, 5. Urologist. Professor of Urology. University of Valencia. Dr Peset Hospital of Valencia
Mathematical or statistical modelling, Pediatrics, Physiology, Voiding Diary

15:25

#180 Long term follow-up after transurethral treatment of infravesical obstruction in boys.

Presenter: Pauline Hennus

Hennus P¹, Kieft J¹, Hoenjet E¹, de Jong T¹, Bosch J L H R¹, de Kort L¹
1. UMC Utrecht
Bladder Outlet Obstruction , Incontinence, Voiding Dysfunction , Male